The natural history of hepatitis C virus (HCV) infection in human immunodeficiency virus (HIV)-infected patients has never been studied according to the concept of liver fibrosis progression. The aim of this work was to assess the fibrosis progression rate in HIV-HCV coinfected patients and in patie
Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients
β Scribed by Sagnelli, Caterina; Uberti-Foppa, Caterina; Galli, Laura; Pasquale, Giuseppe; Coppola, Nicola; Albarello, Luca; Doglioni, Carlo; Lazzarin, Adriano; Sagnelli, Evangelista
- Book ID
- 122285856
- Publisher
- SciELO
- Year
- 2014
- Tongue
- English
- Weight
- 516 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1413-8670
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A few studies have assessed the observed fibrosis progression between serial liver biopsies (LB) in human immunodeficiency virus (HIV) / hepatitis C virus (HCV)-coinfected patients. Approximately half of the patients progressed at least one fibrosis stage over a short period of time. The risk factor
Spontaneous resolution of chronic hepatitis C virus (HCV) infection is exceedingly rare and poorly understood. As HCV and human immunodeficiency virus (HIV) have shared routes of transmission, HCV coinfection is estimated to affect 15%-30% of the HIV-positive population. We report 2 patients with HC